LMC Diabetes & Endocrinology Ltd.   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Toronto Canada

Organization Overview

First Clinical Trial
2016
NCT02682680
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

LMC Clinical Research Inc. | LMC Diabetes | LMC Diabetes & Endocrinology Ltd.